Immunohistochemical determination of estrogen and progesterone receptor positivity in uterine adenosarcoma.

[1]  P. Neven,et al.  THE DIAGNOSTIC PROBLEM OF ENDOMETRIAL STROMAL SARCOMA: REPORT ON SIX CASES , 2003, International Journal of Gynecologic Cancer.

[2]  G. Mor,et al.  Low-grade endometrial stromal sarcoma: hormonal aspects. , 2003, Gynecologic oncology.

[3]  F. Amant,et al.  Immunohistochemical determination of hormone receptors in uterine adenosarcomas. , 2003, Gynecologic Oncology.

[4]  F. Muggia,et al.  Use of medroxyprogesterone acetate in the treatment of Müllerian adenosarcoma: a case report. , 2002, Gynecologic oncology.

[5]  C. Michener,et al.  Ovarian conservation in a woman of reproductive age with müllerian adenosarcoma. , 2001, Gynecologic oncology.

[6]  T. Krivak,et al.  Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival. , 2001, Gynecologic oncology.

[7]  S. Ushigome,et al.  Adenosarcoma of the uterine corpus associated with ovarian thecoma , 2001, Pathology international.

[8]  L. Schwartz,et al.  Endometrial stromal sarcoma: objective response to letrozole. , 2001, Gynecologic oncology.

[9]  D Barnes,et al.  Immunohistochemical detection of steroid receptors in breast cancer: a working protocol , 2000, Journal of clinical pathology.

[10]  F. Guidozzi,et al.  Management of uterine Müllerian adenosarcoma with extrauterine metastatic deposits. , 2000, Gynecologic oncology.

[11]  S. Regauer,et al.  Expression of oestrogen and progesterone receptors in low-grade endometrial stromal sarcomas , 2000, British Journal of Cancer.

[12]  Roberts,et al.  Müllerian adenosarcoma of the uterus in association with tamoxifen therapy , 2000, Histopathology.

[13]  H. Mignotte,et al.  Tamoxifen and malignant epithelial-nonepithelial tumours of the endometrium: report of six cases and review of the literature. , 1999, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[14]  C K Osborne,et al.  Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  C. Verschraegen,et al.  Clinicopathologic analysis of mullerian adenosarcoma: the M.D. Anderson Cancer Center experience. , 1998, Oncology reports.

[16]  P. Clement,et al.  Mullerian adenosarcoma of the uterine corpus associated with tamoxifen therapy: a report of six cases and a review of tamoxifen-associated endometrial lesions. , 1996, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[17]  M. Kosty,et al.  Two unusual presentations of müllerian adenosarcoma: case reports, literature review, and treatment considerations. , 1995, Gynecologic oncology.

[18]  T. Kaku,et al.  Adenosarcoma of the Uterus: A Gynecologic Oncology Group Clinicopathologic Study of 31 Cases , 1992, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[19]  K. Chang,et al.  Primary Uterine Endometrial Stromal Neoplasms: A Clinicopathologic Study of 117 Cases , 1990, The American journal of surgical pathology.

[20]  P. Clement,et al.  Mullerian adenosarcoma of the uterus: a clinicopathologic analysis of 100 cases with a review of the literature. , 1990, Human pathology.

[21]  C. Keen,et al.  Progestogen‐induced regression in low‐grade endometrial stromal sarcoma. Case report and literature review , 1989, British journal of obstetrics and gynaecology.

[22]  P. Clement,et al.  Müllerian Adenosarcomas of the Uterus with Sarcomatous Overgrowth: A Clinicopathological Analysis of 10 Cases , 1989, The American journal of surgical pathology.

[23]  P. Tosi,et al.  Estrogen receptor content, immunohistochemically determined by monoclonal antibodies, in endometrial stromal sarcoma , 1989, Obstetrics and gynecology.

[24]  R. Scully,et al.  Endometrial "sarcomas" complicating ovarian thecoma, polycystic ovarian disease and estrogen therapy. , 1985, Gynecologic oncology.

[25]  L. Blumenson,et al.  Uterine endolymphatic stromal myosis: a collaborative study. , 1984, Obstetrics and gynecology.

[26]  V. Baker,et al.  Steroid Receptors in Endolymphatic Stromal Myosis , 1984, Obstetrics and gynecology.

[27]  P. Schnyder,et al.  Endolymphatic stromal myosis. Surgical and hormonal treatment of extensive abdominal recurrence 20 years after hysterectomy , 1982, Cancer.

[28]  Woodruff Jd,et al.  Uterine stromatosis: a report of 33 cases. , 1982 .

[29]  K. Haram,et al.  Endolymphatic stromal myosis , 1975, Virchows Archiv A.

[30]  P. Clement,et al.  Müllerian adenosarcoma of the uterus: A clinicopathologic analysis of ten cases of a distinctive type of müllerian mixed tumor , 1974, Cancer.

[31]  B. Krumholz,et al.  Endolymphatic stromal myosis with pulmonary metastases. Remission with progestin therapy: report of a case. , 1973, The Journal of reproductive medicine.

[32]  C. Toker.  Concurrence of endometrial stromal malignancy with ovarian theca cell tumor. , 1970, American journal of obstetrics and gynecology.

[33]  R. Spiro,et al.  ENDOMETRIAL STROMAL SARCOMA. , 1965, Surgery, gynecology & obstetrics.

[34]  J. Živný,et al.  Adenosarcoma of the uterine body in a 19-year-old woman--three year survival: case report. , 2001, European Journal of Gynaecological Oncology.

[35]  Feaki ns.  Diversion proctocolitis with granulomatous vasculitis in a patient without inflammatory bowel disease. , 2000 .

[36]  B. Piura,et al.  Mullerian adenosarcoma of the uterus: case report and review of literature. , 2000, European Journal of Gynaecological Oncology.

[37]  T. Bocklage,et al.  Uterine mullerian adenosarcoma following adenomyoma in a woman on tamoxifen therapy. , 1992, Gynecologic oncology.